Detail page

Knowledge Web

Person

Jan-Peter Sowa

Biologe

Name	Jan-Peter Sowa
Place	Deutschland
Gender	männlich
Academic degree	Dr. rer. nat.
Profession	Biologe (characteristic profession)
Further information	Zentrum für Innere Medizin, Universitätsklinikum Essen
Source	AM
Record type	Person
GND-Identifier	1071577808
Record ID	1071577808
Involved in show all Liver Stiffness Determined by Transient Elastography Is a Simple and Highly Accurate Predictor for Presence of Liver Cirrhosis in Clinical Routine Increase of radiologically determined muscle area in patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt Patients with NAFLD exhibit more advanced fibrosis in liver biopsy than patients with other chronic liver diseases Performance of the Liver Maximum Function Capacity Test, Fibrinogen, and Transient Elastography in Patients with Acute Liver Injury Mechanisms and aetiology-dependent treatment of acute liver failure Transaminase Concentrations Cannot Separate Non-Alcoholic Fatty Liver and Non-Alcoholic Steatohepatitis in Morbidly Obese Patients Irrespective of Histological Algorithm Lipoprotein and Metabolic Profiles Indicate Similar Cardiovascular Risk of Liver Steatosis and NASH Transaminase concentrations cannot separate non-alcoholic fatty liver and non-alcoholic steatohepatitis in morbidly obese patients irrespective of histological algorithm Lipoprotein and Metabolic Profiles Indicate Similar Cardiovascular Risk of Liver Steatosis and NASH Significance of simple steatosis : an update on the clinical and molecular evidence l-Ornithine l-Aspartate (LOLA) as a Novel Approach for Therapy of Non-alcoholic Fatty Liver Disease How to Define Acute Liver Failure Patients with Pre-Existing Liver Disease without Signs of Cirrhosis Nonalcoholic-Fatty-Liver-Disease and Nonalcoholic Steatohepatitis: Successful Development of Pharmacological Treatment Will Depend on Translational Research Die Nicht-alkoholische Fettlebererkrankung : ein globales Gesundheitsproblem mit unterschätztem Risikoprofil SPARC expression is associated with hepatic injury in rodents and humans with non-alcoholic fatty liver disease Die Rolle der Leber im metabolischen Syndrom : Adipositas - Insulinresistenz - NAFLD ; Pathophysiologie, Klinik und Therapieoptionen The role of the liver in metabolic syndrome : obesity - insulin resistance - NAFLD ; pathophysiology, clinical symptoms and treatment options Non-Invasive Separation of Alcoholic and Non-Alcoholic Liver Disease with Predictive Modeling Untersuchungen zur Leberregeneration nach Leberteilresektion Untersuchungen zur Leberregeneration nach Leberteilresektion

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Jan-Peter Sowa

Liver Stiffness Determined by Transient Elastography Is a Simple and Highly Accurate Predictor for Presence of Liver Cirrhosis in Clinical Routine

Increase of radiologically determined muscle area in patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt

Patients with NAFLD exhibit more advanced fibrosis in liver biopsy than patients with other chronic liver diseases

Performance of the Liver Maximum Function Capacity Test, Fibrinogen, and Transient Elastography in Patients with Acute Liver Injury

Mechanisms and aetiology-dependent treatment of acute liver failure

Transaminase Concentrations Cannot Separate Non-Alcoholic Fatty Liver and Non-Alcoholic Steatohepatitis in Morbidly Obese Patients Irrespective of Histological Algorithm

Lipoprotein and Metabolic Profiles Indicate Similar Cardiovascular Risk of Liver Steatosis and NASH

Transaminase concentrations cannot separate non-alcoholic fatty liver and non-alcoholic steatohepatitis in morbidly obese patients irrespective of histological algorithm

Lipoprotein and Metabolic Profiles Indicate Similar Cardiovascular Risk of Liver Steatosis and NASH

Significance of simple steatosis : an update on the clinical and molecular evidence

l-Ornithine l-Aspartate (LOLA) as a Novel Approach for Therapy of Non-alcoholic Fatty Liver Disease

How to Define Acute Liver Failure Patients with Pre-Existing Liver Disease without Signs of Cirrhosis

Nonalcoholic-Fatty-Liver-Disease and Nonalcoholic Steatohepatitis: Successful Development of Pharmacological Treatment Will Depend on Translational Research

Die Nicht-alkoholische Fettlebererkrankung : ein globales Gesundheitsproblem mit unterschätztem Risikoprofil

SPARC expression is associated with hepatic injury in rodents and humans with non-alcoholic fatty liver disease

Die Rolle der Leber im metabolischen Syndrom : Adipositas - Insulinresistenz - NAFLD ; Pathophysiologie, Klinik und Therapieoptionen

The role of the liver in metabolic syndrome : obesity - insulin resistance - NAFLD ; pathophysiology, clinical symptoms and treatment options

Non-Invasive Separation of Alcoholic and Non-Alcoholic Liver Disease with Predictive Modeling

Untersuchungen zur Leberregeneration nach Leberteilresektion

Untersuchungen zur Leberregeneration nach Leberteilresektion